About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,321 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,321 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 721-740 of 42,321 trials

TerminatedA Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS)This is an open-label, dose escalation and dose expansion, multi-center phase I study evaluating the safety and tolerability of CF33-CD19 administered intravenously (IV) or…NCT06063317·Duarte, California and 7 others CompletedSafety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal WomenStudy if WC3011 is effective and safe in the treatment of postmenopausal vaginal dryness due to vulvovaginal atrophy.NCT01400776·Huntsville, Alabama and 69 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

TerminatedStudy to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in adults and children, but most cases occur in adults.NCT06068868·Duarte, California and 23 others

RecruitingFood as Medicine StudyThe Food as Medicine (FAME) intervention aims to improve dietary quality in lower income, primarily ethnic minority youth through food navigation that bridges clinical care and…NCT07162350·Dallas, Texas

CompletedBinocular Dig Rush Game Treatment for AmblyopiaTo compare the efficacy of 1 hour/day of binocular game play 5 days per week plus spectacle correction with spectacle correction only, for treatment of amblyopia in children 4 to…NCT02983552·Birmingham, Alabama and 61 others

CompletedProspective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use CasesThis is a prospective uncontrolled observational study to evaluate clinical outcomes following use of the ReCell Autologous Cell Harvesting Device (ReCell) as an adjunct for…NCT02992249·Mobile, Alabama and 21 others

CompletedSafety and Effectiveness Study of Actinic Keratosis Treatment Following CryosurgeryThe objective of this study is to evaluate the efficacy and safety of imiquimod cream versus placebo cream when used after cryosurgery in the treatment of actinic keratoses (AKs).NCT00894647·Los Angeles, California and 17 others

CompletedLenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])This is a study of pembrolizumab (MK-3475, KEYTRUDA®) in combination with lenvatinib (E7080) versus treatment of physician's choice (doxorubicin or paclitaxel) for the treatment…NCT03517449·Phoenix, Arizona and 168 others

CompletedAlgorithm Using LINQ Sensors for Evaluation And Treatment of Heart FailureThe ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study.NCT04452149·Mesa, Arizona and 52 others

CompletedIncreased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)People with CF have a high incidence of diabetes, called CFRD.NCT00082238·Dallas, Texas

UnknownStudy to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal SyndromeThis study aims to evaluate the safety, tolerability and efficacy of R2R01 combined with terlipressin as compared to terlipressin alone in the treatment of patients with HRS-AKINCT05875948·San Francisco, California and 6 others

RecruitingA Study of COVID-19 Vaccine(s) in Children and AdultsThe purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5 Through 64 Years of Age with risk factors for…NCT07798648·Homestead, Florida and 13 others

WithdrawnAdjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)Sturge Weber Syndrome (SWS) is a rare disease that affects the patient's brain and causes benign (non-cancerous) tumors to grow in the brain.NCT01997255·Houston, Texas

CompletedA Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season.NCT00412555·West Palm Beach, Florida and 5 others

TerminatedA Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsThis study is a dose escalation, and cohort expansion study in subjects with advanced cancer for which no standard therapy exists.NCT02440685·Tempe, Arizona and 13 others

CompletedStudy to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)This is an open-label, multicenter, biomarker study designed to be hypothesis-generating in order to better understand the mechanism of action of ocrelizumab and B-cell biology in…NCT02688985·Palo Alto, California and 16 others

CompletedSafety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyThe purpose of this study is to determine the safety and tolerability of MS-R001 at escalating doses in patients with diabetic macular edema secondary to diabetic retinopathyNCT00401115·Phoenix, Arizona and 1 other

CompletedCabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerThis randomized phase II trial studies how well giving cabozantinib-s-malate or paclitaxel works in treating patients with persistent or recurrent epithelial ovarian, fallopian…NCT01716715·Mobile, Alabama and 172 others

CompletedPARTNER II Trial: S3iCAPFollowing completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis…NCT02687035·La Jolla, California and 55 others

RecruitingStudy to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia AreataThis study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss.NCT07133308·Birmingham, Alabama and 63 others

PreviousPage 37 of 2117Next

Heart Diseasein Texas